Krystal Biotech, Inc. (KRYS)
USD 156.64
(-7.34%)
USD 156.64
(-7.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -88.8 Million | -100.56 Million | -47.93 Million | -26.08 Million | -18.71 Million | -9.44 Million |
| Net Income | 10.93 Million | -139.97 Million | -69.57 Million | -32.16 Million | -19.08 Million | -10.88 Million |
| Depreciation & Amortization | 5 Million | 4.05 Million | 2.76 Million | 1.85 Million | 748 Thousand | 141 Thousand |
| Deferred income taxes | 46.61 Million | - | - | - | - | - |
| Stock-based compensation | 39.93 Million | 33.23 Million | 15.31 Million | 3.27 Million | 1.23 Million | 792 Thousand |
| Change in working capital | -37.88 Million | 2.81 Million | 2.05 Million | 928 Thousand | -1.67 Million | 511 Thousand |
| Other non-cash items | -153.41 Million | -690 Thousand | 1.49 Million | 33 Thousand | 67 Thousand | 962 Thousand |
| Investing Cash Flow | 82.63 Million | -114.08 Million | -226.77 Million | -11.18 Million | -4.96 Million | -10.32 Million |
| Investments in PPE | -11.79 Million | -52.97 Million | -68.33 Million | -14.84 Million | -6.39 Million | -2.23 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -508.77 Million | -318.78 Million | -190.46 Million | -3.2 Million | -9.07 Million | -8.08 Million |
| Sales/Maturities of investments | 503.21 Million | 257.67 Million | 32.02 Million | 6.86 Million | 10.5 Million | - |
| Other Investing Activities | 100 Million | - | - | - | - | - |
| Financing Cash Flow | 202.75 Million | 35.34 Million | 347.68 Million | 118.01 Million | 107.52 Million | 73.84 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 203.49 Million | 35.99 Million | 355.64 Million | 118.01 Million | 107.52 Million | 73.84 Million |
| Other Financing Activities | -749 Thousand | -649 Thousand | -7.96 Million | - | - | - |
| Accounts receivables | -42.04 Million | - | - | - | - | - |
| Accounts payables | -101 Thousand | -1.25 Million | 712 Thousand | 783 Thousand | -199 Thousand | 112 Thousand |
| Inventory | -4.47 Million | - | - | - | - | - |
| Other working capital | 8.73 Million | 4.06 Million | 1.34 Million | 145 Thousand | -1.48 Million | 399 Thousand |
| Cash at beginning of period | 161.9 Million | 341.24 Million | 268.26 Million | 187.51 Million | 103.67 Million | 49.59 Million |
| Cash at end of period | 358.32 Million | 161.9 Million | 341.24 Million | 268.26 Million | 187.51 Million | 103.67 Million |
| Capital Expenditure | -11.79 Million | -52.97 Million | -68.33 Million | -14.84 Million | -6.39 Million | -2.23 Million |
| Effect of forex changes on cash | -156 Thousand | -41 Thousand | - | - | - | - |
| Net cash flow / Change in cash | 196.42 Million | -179.34 Million | 72.97 Million | 80.75 Million | 83.84 Million | 54.07 Million |
| Free Cash Flow | -100.6 Million | -153.54 Million | -116.27 Million | -40.92 Million | -25.11 Million | -11.67 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 27.18 Million | 15.56 Million | 932 Thousand | 10.93 Million | 8.69 Million | 80.74 Million |
| Depreciation & Amortization | 1.56 Million | 1.98 Million | 1.6 Million | 5 Million | 1.5 Million | 826 Thousand |
| Deferred income taxes | - | - | - | 46.61 Million | -46.3 Million | -100 Million |
| Stock-based compensation | 13.31 Million | 13.15 Million | 9.29 Million | 39.93 Million | 9.85 Million | 8.31 Million |
| Change in working capital | 26.99 Million | -33.29 Million | 6.3 Million | -37.88 Million | -25.71 Million | -9.19 Million |
| Other non-cash items | -10.19 Million | 70.99 Million | -238 Thousand | -153.41 Million | 44.73 Million | -1.91 Million |
| Investing Cash Flow | -34.32 Million | -19.35 Million | -25.98 Million | 82.63 Million | -10.16 Million | 105.19 Million |
| Investments in PPE | -1.04 Million | -1.13 Million | -1.26 Million | -11.79 Million | -1.84 Million | -1.78 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -112.53 Million | -113.4 Million | -88.33 Million | -508.77 Million | -82.9 Million | -105.9 Million |
| Sales/Maturities of investments | 79.25 Million | 95.17 Million | 63.61 Million | 503.21 Million | 74.59 Million | 112.87 Million |
| Other Investing Activities | - | - | - | 100 Million | - | 100 Million |
| Financing Cash Flow | 3.36 Million | 10.63 Million | 10.58 Million | 202.75 Million | 2.61 Million | 13.38 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -26.6 Million | 10.63 Million | 15.96 Million | 203.49 Million | 2.61 Million | 13.38 Million |
| Other Financing Activities | 29.97 Million | 10.63 Million | -5.38 Million | -749 Thousand | - | - |
| Accounts receivables | 5.93 Million | -56.76 Million | -4.42 Million | -42.04 Million | -32.72 Million | -9.31 Million |
| Accounts payables | 91 Thousand | 784 Thousand | 727 Thousand | -101 Thousand | -222 Thousand | -360 Thousand |
| Inventory | -3.67 Million | 530 Thousand | -2.23 Million | -4.47 Million | -492 Thousand | -3.07 Million |
| Other working capital | -34.4 Million | 22.16 Million | 12.23 Million | 8.73 Million | 7.72 Million | -8.83 Million |
| Cash at beginning of period | 345.78 Million | 359 Million | 358.32 Million | 161.9 Million | 373.24 Million | 275.87 Million |
| Cash at end of period | 373.96 Million | 345.78 Million | 359 Million | 358.32 Million | 358.32 Million | 373.24 Million |
| Capital Expenditure | -1.04 Million | -1.13 Million | -1.26 Million | -11.79 Million | -1.84 Million | -1.78 Million |
| Effect of forex changes on cash | 286 Thousand | -337 Thousand | 187 Thousand | -156 Thousand | -140 Thousand | 12 Thousand |
| Net cash flow / Change in cash | 28.18 Million | -13.22 Million | 678 Thousand | 196.42 Million | -14.91 Million | 97.36 Million |
| Free Cash Flow | 57.81 Million | -5.29 Million | 14.62 Million | -100.6 Million | -9.07 Million | -23 Million |
SAPPL
KAYNES
9788
7931
8029
NNAG